U
SpyGlass Pharma, Inc. SGP
$24.48 $0.341.41% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025
Total Cash And Short-Term Investments 560.41%
Total Receivables 1.89%
Inventory --
Prepaid Expenses 26.01%
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets 524.89%

Total Current Assets 524.89%
Net Property, Plant & Equipment -28.72%
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets 607.95%
Total Assets 396.90%

Total Accounts Payable 36.30%
Total Accrued Expenses 70.20%
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities -9.37%
Total Other Current Liabilities -9.37%
Total Current Liabilities 10.18%

Total Current Liabilities 10.18%
Long-Term Debt --
Short-term Debt --
Capital Leases -54.21%
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities -9.60%

Common Stock & APIC 34.33%
Retained Earnings -61.47%
Treasury Stock & Other --
Total Common Equity -63.44%

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible 181.94%
Preferred Stock, Others --
Total Preferred Equity 181.94%

Total Common Equity -63.44%
Total Preferred Equity 181.94%
Total Minority Interest --
Total Equity 775.58%